LXRX Competitors & Alternatives
Compare Lexicon Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
LXRX
Main Stock$1.81
Tradestie Score
38
Market Cap
$512.39M
Revenue Growth
-0.2%
Analyst Upside
+150.1%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
FTRE
Fortrea Holdings Inc. Common Stock
|
$19.98
|
$864.42M | - | 55 | Compare |
|
SEPN
Septerna, Inc. Common Stock
|
$43.00
|
$847.12M | - | 47 | Compare |
|
XNCR
Xencor, Inc.
|
$38.40
|
$843.75M | - | 30 | Compare |
|
GHRS
GH Research PLC Ordinary Shares
|
$18.51
|
$841.74M | - | 40 | Compare |
|
KOD
Kodiak Sciences Inc Common Stock
|
$108.16
|
$832.47M | - | 36 | Compare |
|
URGN
UroGen Pharma Ltd. Ordinary Shares
|
$26.33
|
$824.20M | - | 61 | Compare |
|
IVA
Inventiva S.A. American Depository Shares
|
$3.92
|
$821.84M | - | 26 | Compare |
|
MBX
MBX Biosciences, Inc. Common Stock
|
$54.96
|
$800.41M | - | 47 | Compare |
|
IOVA
Iovance Biotherapeutics, Inc. Common Stock
|
$7.84
|
$799.70M | - | 59 | Compare |
|
KURA
Kura Oncology, Inc.
|
$7.49
|
$798.53M | - | 59 | Compare |
More LXRX Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
218 stocks in this industry